Womb fluid injections could give babies with no kidneys a chance to breathe

NCT ID NCT03723564

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether repeatedly injecting a sterile saltwater solution into the womb can help fetuses with severe kidney problems grow their lungs. Normally, these babies have too little amniotic fluid, which prevents the lungs from developing. The goal is to see if this procedure is safe and can help enough babies survive to start dialysis or get a kidney transplant after birth. The study involves 40 pregnant women and their fetuses.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Lactated Ringer's solution (a sterile saltwater-like fluid)

What this could lead to

If it works, this could allow babies born with severe kidney problems to survive long enough to start dialysis or receive a kidney transplant.

What could go wrong

This is a very early feasibility study with only 40 participants. The procedure may not improve lung growth enough, and there are risks of infection, preterm labor, or other complications for both mother and baby.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL FAILURE CONGENITAL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bilateral renal agenesis Congenital Abnormalities congenital anomaly of kidney and urinary tract Hereditary renal agenesis renal agenesis urinary tract obstruction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact